CN114478213A - 一种利用微通道器制备依他佐辛中间体的方法 - Google Patents
一种利用微通道器制备依他佐辛中间体的方法 Download PDFInfo
- Publication number
- CN114478213A CN114478213A CN202011148497.3A CN202011148497A CN114478213A CN 114478213 A CN114478213 A CN 114478213A CN 202011148497 A CN202011148497 A CN 202011148497A CN 114478213 A CN114478213 A CN 114478213A
- Authority
- CN
- China
- Prior art keywords
- reaction
- compound
- temperature
- solution
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 21
- ZOWQTJXNFTWSCS-IAQYHMDHSA-N eptazocine Chemical compound C1N(C)CC[C@@]2(C)C3=CC(O)=CC=C3C[C@@H]1C2 ZOWQTJXNFTWSCS-IAQYHMDHSA-N 0.000 title claims abstract description 10
- 229950010920 eptazocine Drugs 0.000 title claims abstract description 10
- 238000006243 chemical reaction Methods 0.000 claims abstract description 75
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 11
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 26
- 238000002360 preparation method Methods 0.000 claims description 19
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 18
- 229940126214 compound 3 Drugs 0.000 claims description 17
- 150000001875 compounds Chemical class 0.000 claims description 17
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 15
- 229940125782 compound 2 Drugs 0.000 claims description 15
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 9
- 229940125904 compound 1 Drugs 0.000 claims description 8
- NXPHGHWWQRMDIA-UHFFFAOYSA-M magnesium;carbanide;bromide Chemical compound [CH3-].[Mg+2].[Br-] NXPHGHWWQRMDIA-UHFFFAOYSA-M 0.000 claims description 7
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 6
- 239000002841 Lewis acid Substances 0.000 claims description 5
- 238000005859 coupling reaction Methods 0.000 claims description 5
- 150000007517 lewis acids Chemical class 0.000 claims description 5
- FSVURZLTNBDPLB-UHFFFAOYSA-N 1-ethoxyethoxy(trimethyl)silane Chemical group CCOC(C)O[Si](C)(C)C FSVURZLTNBDPLB-UHFFFAOYSA-N 0.000 claims description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 4
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 4
- FWSPEQUVBXPDCL-UHFFFAOYSA-N bis(2-methylpropyl)alumanylformonitrile Chemical compound CC(C)C[Al](C#N)CC(C)C FWSPEQUVBXPDCL-UHFFFAOYSA-N 0.000 claims description 4
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical group FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 claims description 4
- 230000008878 coupling Effects 0.000 claims description 4
- 238000010168 coupling process Methods 0.000 claims description 4
- PSCMQHVBLHHWTO-UHFFFAOYSA-K indium(iii) chloride Chemical compound Cl[In](Cl)Cl PSCMQHVBLHHWTO-UHFFFAOYSA-K 0.000 claims description 4
- 239000011968 lewis acid catalyst Substances 0.000 claims description 4
- 229910052710 silicon Inorganic materials 0.000 claims description 4
- 239000010703 silicon Substances 0.000 claims description 4
- XJDNKRIXUMDJCW-UHFFFAOYSA-J titanium tetrachloride Chemical compound Cl[Ti](Cl)(Cl)Cl XJDNKRIXUMDJCW-UHFFFAOYSA-J 0.000 claims description 4
- VXUYXOFXAQZZMF-UHFFFAOYSA-N titanium(IV) isopropoxide Chemical compound CC(C)O[Ti](OC(C)C)(OC(C)C)OC(C)C VXUYXOFXAQZZMF-UHFFFAOYSA-N 0.000 claims description 4
- CTLFKOLROMXRLE-UHFFFAOYSA-M CC1OCCC1.[Br-].C[Mg+] Chemical compound CC1OCCC1.[Br-].C[Mg+] CTLFKOLROMXRLE-UHFFFAOYSA-M 0.000 claims description 3
- VHHPDZDTKZOHTB-UHFFFAOYSA-M [Br-].[Mg+]C.C1CCOC1 Chemical compound [Br-].[Mg+]C.C1CCOC1 VHHPDZDTKZOHTB-UHFFFAOYSA-M 0.000 claims description 3
- JVEKTRVIOXQWMF-UHFFFAOYSA-M [Br-].[Mg+]C.CC1=CC=CC=C1 Chemical compound [Br-].[Mg+]C.CC1=CC=CC=C1 JVEKTRVIOXQWMF-UHFFFAOYSA-M 0.000 claims description 3
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 claims description 2
- 229910015900 BF3 Inorganic materials 0.000 claims description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 claims description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 claims description 2
- VMPVEPPRYRXYNP-UHFFFAOYSA-I antimony(5+);pentachloride Chemical compound Cl[Sb](Cl)(Cl)(Cl)Cl VMPVEPPRYRXYNP-UHFFFAOYSA-I 0.000 claims description 2
- 238000006555 catalytic reaction Methods 0.000 claims description 2
- 239000003638 chemical reducing agent Substances 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 claims description 2
- 229910000077 silane Inorganic materials 0.000 claims description 2
- 239000007810 chemical reaction solvent Substances 0.000 claims 2
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 abstract description 12
- 238000003786 synthesis reaction Methods 0.000 abstract description 7
- 230000015572 biosynthetic process Effects 0.000 abstract description 6
- 239000003446 ligand Substances 0.000 abstract description 6
- 229910000073 phosphorus hydride Inorganic materials 0.000 abstract description 6
- 239000000463 material Substances 0.000 abstract description 5
- 230000003321 amplification Effects 0.000 abstract description 4
- 239000003054 catalyst Substances 0.000 abstract description 4
- 238000003199 nucleic acid amplification method Methods 0.000 abstract description 4
- 238000005265 energy consumption Methods 0.000 abstract description 2
- 229910001385 heavy metal Inorganic materials 0.000 abstract description 2
- 230000035484 reaction time Effects 0.000 abstract description 2
- 238000007086 side reaction Methods 0.000 abstract description 2
- 239000007858 starting material Substances 0.000 abstract description 2
- 239000012612 commercial material Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 49
- 239000012074 organic phase Substances 0.000 description 31
- 239000007788 liquid Substances 0.000 description 29
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 17
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- 238000003756 stirring Methods 0.000 description 15
- 238000010791 quenching Methods 0.000 description 13
- -1 aromatic iodo compound Chemical class 0.000 description 12
- 238000005406 washing Methods 0.000 description 11
- 238000009833 condensation Methods 0.000 description 10
- 230000005494 condensation Effects 0.000 description 10
- 239000012043 crude product Substances 0.000 description 10
- 230000000171 quenching effect Effects 0.000 description 10
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 9
- 239000007864 aqueous solution Substances 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 238000001816 cooling Methods 0.000 description 5
- 230000002194 synthesizing effect Effects 0.000 description 5
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 4
- CXWXQJXEFPUFDZ-UHFFFAOYSA-N tetraline Natural products C1=CC=C2CCCCC2=C1 CXWXQJXEFPUFDZ-UHFFFAOYSA-N 0.000 description 4
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical class [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 3
- 125000003172 aldehyde group Chemical group 0.000 description 3
- 150000001350 alkyl halides Chemical class 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000012065 filter cake Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000009776 industrial production Methods 0.000 description 3
- 150000002940 palladium Chemical class 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- KMISFPIWSMSMJD-GPKQSYPGSA-N Eptazocine hydrobromide Chemical compound Br.C1N(C)CC[C@@]2(C)C3=CC(O)=CC=C3C[C@@H]1C2 KMISFPIWSMSMJD-GPKQSYPGSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- 239000012527 feed solution Substances 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 102000005962 receptors Human genes 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- LAPWDCHUQSJIRB-UHFFFAOYSA-N 1-iodo-2-phenylmethoxybenzene Chemical compound IC1=CC=CC=C1OCC1=CC=CC=C1 LAPWDCHUQSJIRB-UHFFFAOYSA-N 0.000 description 1
- RIXZIFTXNDAKLT-UHFFFAOYSA-N 6-bromo-3-methylhex-2-en-1-ol Chemical compound OCC=C(C)CCCBr RIXZIFTXNDAKLT-UHFFFAOYSA-N 0.000 description 1
- 206010058019 Cancer Pain Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- BDJSWOBORORDEB-UHFFFAOYSA-N OCC=C(C)CCCI Chemical compound OCC=C(C)CCCI BDJSWOBORORDEB-UHFFFAOYSA-N 0.000 description 1
- 102000003840 Opioid Receptors Human genes 0.000 description 1
- 108090000137 Opioid Receptors Proteins 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000004550 Postoperative Pain Diseases 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 125000005605 benzo group Chemical group 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- JYRBQCWXZNDERM-XIRDDKMYSA-N etazocine Chemical compound C1C2=CC=C(O)C=C2[C@]2(CC)[C@@H](CC)[C@H]1N(C)CC2 JYRBQCWXZNDERM-XIRDDKMYSA-N 0.000 description 1
- RSIHJDGMBDPTIM-UHFFFAOYSA-N ethoxy(trimethyl)silane Chemical group CCO[Si](C)(C)C RSIHJDGMBDPTIM-UHFFFAOYSA-N 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 125000003518 norbornenyl group Chemical class C12(C=CC(CC1)C2)* 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- 239000012434 nucleophilic reagent Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 239000004031 partial agonist Substances 0.000 description 1
- VOKSWYLNZZRQPF-GDIGMMSISA-N pentazocine Chemical compound C1C2=CC=C(O)C=C2[C@@]2(C)[C@@H](C)[C@@H]1N(CC=C(C)C)CC2 VOKSWYLNZZRQPF-GDIGMMSISA-N 0.000 description 1
- 229960005301 pentazocine Drugs 0.000 description 1
- 230000001242 postsynaptic effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/41—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by hydrogenolysis or reduction of carboxylic groups or functional derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
- C07C41/01—Preparation of ethers
- C07C41/18—Preparation of ethers by reactions not forming ether-oxygen bonds
- C07C41/30—Preparation of ethers by reactions not forming ether-oxygen bonds by increasing the number of carbon atoms, e.g. by oligomerisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011148497.3A CN114478213B (zh) | 2020-10-23 | 2020-10-23 | 一种利用微通道器制备依他佐辛中间体的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011148497.3A CN114478213B (zh) | 2020-10-23 | 2020-10-23 | 一种利用微通道器制备依他佐辛中间体的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114478213A true CN114478213A (zh) | 2022-05-13 |
CN114478213B CN114478213B (zh) | 2023-12-08 |
Family
ID=81470150
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011148497.3A Active CN114478213B (zh) | 2020-10-23 | 2020-10-23 | 一种利用微通道器制备依他佐辛中间体的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114478213B (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102159551A (zh) * | 2008-09-22 | 2011-08-17 | 巴斯夫欧洲公司 | 咪唑和三唑化合物、其应用和含有它们的试剂 |
WO2012114252A1 (en) * | 2011-02-21 | 2012-08-30 | Actelion Pharmaceuticals Ltd | Novel indole and pyrrolopyridine amides |
CN105439978A (zh) * | 2015-12-15 | 2016-03-30 | 山东金城医药化工股份有限公司 | 阿考替胺中间体的制备方法 |
-
2020
- 2020-10-23 CN CN202011148497.3A patent/CN114478213B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102159551A (zh) * | 2008-09-22 | 2011-08-17 | 巴斯夫欧洲公司 | 咪唑和三唑化合物、其应用和含有它们的试剂 |
WO2012114252A1 (en) * | 2011-02-21 | 2012-08-30 | Actelion Pharmaceuticals Ltd | Novel indole and pyrrolopyridine amides |
CN105439978A (zh) * | 2015-12-15 | 2016-03-30 | 山东金城医药化工股份有限公司 | 阿考替胺中间体的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN114478213B (zh) | 2023-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113999160B (zh) | 一种6,6-二甲基-3-氮杂双环[3.1.0]己烷的制备方法 | |
US11708321B2 (en) | Method for preparing (dimethylaminomethylene) malononitrile using a micro reaction system | |
CN113582910B (zh) | 一种以咔唑为原料的1-溴咔唑的合成方法 | |
CN108250060B (zh) | 5-溴-2-氯苯甲酸的合成方法 | |
CN111454286A (zh) | 一种二氟烯基硼化合物的合成方法 | |
CN114478213B (zh) | 一种利用微通道器制备依他佐辛中间体的方法 | |
CN107235891B (zh) | 一种4-溴咔唑的制备方法 | |
CN112174832B (zh) | 一种一步合成5-氯-2-甲基-4-(三氟甲基)苯胺的方法 | |
CN108586529A (zh) | 一种含有联苯骨架的手性化合物及其制备方法与应用 | |
CN113943231A (zh) | 一种1-羟甲基环丙基乙腈的制备方法 | |
CN109678673B (zh) | 一种芳基取代的高烯丙醇的合成方法 | |
CN113773182A (zh) | 一种合成6,8-二氯辛酸酯的方法 | |
CN108440433B (zh) | 铜路易斯酸表面活性剂催化制备氯化-3-取代-2,5-二苯基四氮唑的方法 | |
CN113956123B (zh) | 一种2-烷基蒽的制备方法和用途 | |
CN108863900A (zh) | 一种5-氟吲哚-2-酮的制备方法 | |
CN114920635B (zh) | 4-羟基-1-茚酮的制备方法 | |
CN114478211A (zh) | 一种依他佐辛中间体的制备方法 | |
CN102807468B (zh) | 一种丙基邻氟苯类化合物的制备方法 | |
CN114736239B (zh) | 一种双齿膦配体及其制备方法、应用 | |
CN109096027B (zh) | 三苯基甲烷的合成方法 | |
CN116063209B (zh) | 可见光促进镍催化苄基c-h键胺化制备苄胺衍生物的方法 | |
CN112321433B (zh) | 一种3-(羟甲基)环己烷羧酸叔丁酯的合成方法 | |
CN114213373B (zh) | 二苯并呋喃类衍生物的合成方法 | |
CN113956268B (zh) | 一种6-溴-1-氯苯并噻吩[2,3-c]吡啶及合成方法 | |
CN117050010B (zh) | 一种2,2’-联喹啉及其衍生物的合成方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20221125 Address after: No.6 Dongbo Road, East District, Guangzhou Economic and Technological Development Zone, Guangdong 510000 Applicant after: GUANGZHOU YIPINHONG PHARMACEUTICAL Co.,Ltd. Applicant after: GUANGDONG ZERUI PHARMACEUTICAL Co.,Ltd. Applicant after: Guangzhou Lianrui Pharmaceutical Co.,Ltd. Applicant after: Guangzhou Runlin Pharmaceutical Technology Co.,Ltd. Applicant after: Euphorbia Biological Medicine Co.,Ltd. Address before: No.6 Dongbo Road, East District, Guangzhou Economic and Technological Development Zone, Guangdong 510000 Applicant before: GUANGZHOU YIPINHONG PHARMACEUTICAL Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20230206 Address after: No.6 Dongbo Road, East District, Guangzhou Economic and Technological Development Zone, Guangdong 510000 Applicant after: GUANGZHOU YIPINHONG PHARMACEUTICAL Co.,Ltd. Applicant after: GUANGDONG ZERUI PHARMACEUTICAL Co.,Ltd. Applicant after: Guangzhou Lianrui Pharmaceutical Co.,Ltd. Applicant after: Guangzhou Runlin Pharmaceutical Technology Co.,Ltd. Applicant after: Euphorbia Biological Medicine Co.,Ltd. Applicant after: Guangdong Ruishi Pharmaceutical Technology Co.,Ltd. Address before: No.6 Dongbo Road, East District, Guangzhou Economic and Technological Development Zone, Guangdong 510000 Applicant before: GUANGZHOU YIPINHONG PHARMACEUTICAL Co.,Ltd. Applicant before: GUANGDONG ZERUI PHARMACEUTICAL Co.,Ltd. Applicant before: Guangzhou Lianrui Pharmaceutical Co.,Ltd. Applicant before: Guangzhou Runlin Pharmaceutical Technology Co.,Ltd. Applicant before: Euphorbia Biological Medicine Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant |